Reports for TEVA-SPIRONOLACTONE/HCTZ
Brand name
TEVA-SPIRONOLACTONE/HCTZ
Company Name
TEVA CANADA LIMITED
|
Drug Identification Number
00657182 |
Ingredients
HYDROCHLOROTHIAZIDE SPIRONOLACTONE |
Ingredient Strength
50 MG 50 MG |
ATC Code
C03EAC03EA |
ATC Descriptor
DIURETICS AND POTASSIUM-SPARING AGENTS IN COMB DIURETICS AND POTASSIUM-SPARING AGENTS IN COMB |
Status
MARKETED
|
Shortage reports
| Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|
| TEVA-SPIRONOLACTONE/HCTZ | 100 | Resolved | 2020-03-26 | 2020-04-23 | 109574 |
| TEVA-SPIRONOLACTONE/HCTZ | 100 | Resolved | 2020-09-03 | 2021-02-05 | 123738 |
| TEVA-SPIRONOLACTONE/HCTZ | 100 | Resolved | 2023-10-26 | 2023-11-09 | 208251 |
| TEVA-SPIRONOLACTONE/HCTZ | 100 | Resolved | 2025-07-18 | 2025-08-29 | 263113 |
Showing 1 to 4 of 4
Discontinuation reports
| Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
|---|
Showing 1 to 0 of 0